This study collected quality-of-life measures that can guide future patients' decisions.
More young women have been opting for mastectomy, even bilateral mastectomy, when breast-conserving therapy (BCT) is an appropriate choice. Assessing the long-term quality-of-life (QOL) outcomes of those who choose different options can inform future patients facing these decisions.
The Young Women's Breast Cancer Study — a large, multicenter, prospective, cross-sectional study of a cohort diagnosed with breast cancer between 2016 and 2017 — examined 560 patients (median age, 36) at stage 0–II. At a median of 5.8 years from diagnosis, 86% completed a QOL assessment using the BREAST-Q instrument, which has modules for each surgical option: BCT, mastectomy without reconstruction, and mastectomy with reconstruction. Several domains are evaluate…
Reviewing Author
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)
DisclosuresConsultant/Advisory BoardLilly; AstraZeneca; Gilead
Grant/Research SupportBreast Cancer Research Foundation
Editorial BoardsClinical Breast Cancer; Oncology; Annals of Surgery; Breast Cancer Research and Treatment
Leadership Positions in Professional SocietiesNational Comprehensive Cancer Network (Chair, Breast Cancer Panel); American Board of Internal Medicine (Medical Oncology Board)